Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tissue Repair Ltd ( (AU:TRP) ) has shared an update.
Tissue Repair Ltd has appointed Peter Scutt as a director effective 20 April 2026, and disclosed his initial interests in the company’s securities in accordance with ASX listing rules. The filing shows Scutt holds a substantial package of unlisted options, alongside significant indirect holdings of fully paid ordinary shares through investment and retirement fund structures, underscoring a strong equity alignment with shareholders.
The disclosure of Scutt’s interests clarifies the scale and structure of his financial stake in Tissue Repair at the outset of his board tenure. This level of share and option exposure is likely intended to align governance incentives with long-term shareholder value, and signals the company’s continued emphasis on equity-based participation for its leadership team.
More about Tissue Repair Ltd
Tissue Repair Ltd is a listed company operating in the healthcare and biotechnology sector, focused on developing and commercialising products related to tissue repair and regenerative medicine. The company’s securities are traded on the ASX, and its capital structure includes fully paid ordinary shares and various classes of unlisted options.
Average Trading Volume: 95,310
Technical Sentiment Signal: Sell
Current Market Cap: A$9.98M
Find detailed analytics on TRP stock on TipRanks’ Stock Analysis page.